We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Intraoperative Detection of Residual Cancer in Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03321929
Recruitment Status : Completed
First Posted : October 26, 2017
Last Update Posted : April 1, 2021
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Lumicell, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : April 10, 2020
Actual Study Completion Date : April 10, 2020
Certification/Extension First Submitted : January 29, 2021
Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 January 25, 2023